Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Distinct Phenotypes of Myeloid Neoplasia Associated with Truncating C-CBL Mutations

Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez, Arda Durmaz, Nakisha D Williams, Hussein Awada, Matteo D'Addona, Naomi Kawashima, Arooj Ahmed, Serhan Unlu, Olisaemeka Ogbue, Christopher Haddad, Aashray Mandala, Yasuo Kubota, Juraj Bodo, Genevieve M Crane, Heesun J. Rogers, Jaroslaw Maciejewski, Valeria Visconte

Blood (2024) 144 (Supplement 1): 2920.

https://doi.org/10.1182/blood-2024-209834

Published: 2024

Journal Articles

Molecular and Clinical PHF6 Mutant Myeloid Neoplasia Provides Clues As to Their Pathogenesis and Therapeutic Targeting

Yasuo Kubota, Laila Terkawi, Carmelo Gurnari, Juraj Bodo, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, BEN Ponvilawan, Tariq Kewan, Waled Bahaj, Valeria Visconte, Heesun J. Rogers, Torsten Haferlach, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 8707–8708.

https://doi.org/10.1182/blood-2022-169214

Published: 2022

Journal Articles

Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell Proliferations

Xiaoxian Zhao, PhD, Bartlomiej Przychodzen, Juraj Bodo, PhD, Lisa Durkin, Daniel Lindner, MD PhD, Neetha Parameswaran, PhD, Michael Clemente, MS, Sarah L. Ondrejka, DO, Jaroslaw P. Maciejewski, MD PhD, Deepa Jagadeesh, MDMPH, Eric D. Hsi, MD

Blood (2019) 134 (Supplement_1): 1572.

https://doi.org/10.1182/blood-2019-129131

Published: 2019

Journal Articles

Hypomethylating Agent 5-Azacytidine Sensitizes Peripheral T-Cell Lymphoma to SLAMF7-Targeting Therapeutic Antibody, Elotuzumab

Neetha Parameswaran, PhD, Xiaoxian Zhao, PhD, Juraj Bodo, PhD, Lisa Durkin, Yvonne Parker, Daniel Lindner, MD PhD, Eric D. Hsi, MD, Deepa Jagadeesh, MDMPH

Blood (2019) 134 (Supplement_1): 1515.

https://doi.org/10.1182/blood-2019-131800

Published: 2019

Journal Articles

Inhibition of Cyclin Dependent Kinase 9 Synergistically Enhanced Venetoclax Activity in Mantle Cell Lymphoma Cells

Xiaoxian Zhao, PhD, Juraj Bodo, PhD, Ruoying Chen, PhD, Lisa Durkin, Andrew J. Souers, PhD, Darren C. Phillips, PhD, Eric D. Hsi, MD

Blood (2016) 128 (22): 1593.

https://doi.org/10.1182/blood.V128.22.1593.1593

Published: 2016

Journal Articles

The Synergistic Effect of Venetoclax Combined with a CDK9 Inhibitor in Primary Diffuse Large B Cell Lymphoma and Follicular Lymphoma Cells

Xiaoxian Zhao, PhD, Darren C. Phillips, PhD, Andrew J. Souers, PhD, Juraj Bodo, PhD, Paul Tapang, Daniel H Albert, PhD, Lisa Durkin, Eric D. Hsi, MD

Blood (2015) 126 (23): 2746.

https://doi.org/10.1182/blood.V126.23.2746.2746

Published: 2015

Journal Articles

CCMCL1: a new model of aggressive mantle cell lymphoma

Xiaoxian Zhao, Selina Chen-Kiang, Shashirekha Shetty, Maurizio Di Liberto, Juraj Bodo, Lisa Durkin, Ken Eng, Olivier Elemento, Mitchell R. Smith, Eric D. Hsi

Blood (2015) 125 (17): 2730–2732.

https://doi.org/10.1182/blood-2015-01-622795

Published: 2015

Includes: Supplemental data

Journal Articles

Activity of ABT-199 and Acquired Resistance in Follicular Lymphoma Cells

Juraj Bodo, PhD, Xiaoxian Zhao, PhD, Mitchell R. Smith, MD PhD, Eric D. Hsi, MD

Blood (2014) 124 (21): 3635.

https://doi.org/10.1182/blood.V124.21.3635.3635

Published: 2014

Journal Articles

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Valeria Visconte, PhD, Ali Tabarroki, MD, John Barnard, Li Zhang, Juraj Bodo, PhD, Reda Mahfouz, MD, Betty K. Hamilton, MD, Mikkael Sekeres, Anjali S. Advani, MD, Matt E. Kalaycio, MD, Yogen Saunthararajah, MD, Velizar Shivarov, MD, PhD, Shashirekha Shetty, PhD, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD

Blood (2014) 124 (21): 3250.

https://doi.org/10.1182/blood.V124.21.3250.3250

Published: 2014

Journal Articles

Triple Negative (J AK2 exon 12 /14 and MPL wild type) Myelofibrosis Have Higher Expression Of CDC25A and Greater Sensitivity To CDC25A Inhibition Compared To JAK2 Mutant Cases

Ali Tabarroki, MD, Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, Juraj Bodo, PhD, Li Zhang, Felicitas Lacbawan, Edy Hasrouni, John Barnard, Alan E. Lichtin, Daniel Lindner, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 5259.

https://doi.org/10.1182/blood.V122.21.5259.5259

Published: 2013

Journal Articles

Spliceosome Gene Mutations Are Frequently Found In JAK2 Negative Myelofibrosis and Associated With Worse Clinical Outcomes

Ali Tabarroki, MD, Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, Juraj Bodo, PhD, Li Zhang, Edy Hasrouni, John Barnard, Alan E. Lichtin, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 4063.

https://doi.org/10.1182/blood.V122.21.4063.4063

Published: 2013

Journal Articles

Combination Of Ibrutinib With ABT-199, a BCL-2 Pathway Inhibitor: Effective Therapeutic Strategy In a Novel Mantle Cell Lymphoma Cell Line Model

Xiaoxian Zhao, PhD, Juraj Bodo, PhD, Danyu Sun, MD, PhD, Jeffrey J. Lin, PhD, Lisa Durkin, Shashirekha Shetty, PhD, Mitchell R. Smith, MD, PhD, Eric D. Hsi, MD

Blood (2013) 122 (21): 645.

https://doi.org/10.1182/blood.V122.21.645.645

Published: 2013

Journal Articles

The PI3K Inhibitor GS-1101 (CAL-101) Synergistically Potentiates HDAC-Induced Proliferation Inhibition and Apoptosis Through the Activation of JNK in Lymphoma Cells

Juraj Bodo, PhD, Brian T. Hill, MD, PhD, Xiaoxian Zhao, PhD, Craig A. Portell, MD, Brian J. Lannutti, PhD, Eric D. Hsi, MD

Blood (2012) 120 (21): 3714.

https://doi.org/10.1182/blood.V120.21.3714.3714

Published: 2012

Journal Articles

Single Nucleotide Polymorphism Array (SNP-A) Genomic Profiling of Mantle Cell Lymphoma (MCL) Against a Large Control Database Reveals Recurring Copy Number Alterations (CNAs) and Copy Neutral Loss of Heterozygosity (CN-LOH)

Michael J. Rauh, MD, PhD, Juraj Bodo, MD, Eric Hsi, MD, Bill Richendollar, Yuka Sugimoto, MD, PhD, Jaroslaw P Maciejewski, MD, PhD, FACP, Christine L. O'Keefe, PhD, Stephen D. Smith, MD

Blood (2010) 116 (21): 2001.

https://doi.org/10.1182/blood.V116.21.2001.2001

Published: 2010

Journal Articles

Combination of Enzastaurin and HDAC Inhibitors Synergically Induce Apoptosis in Lymphoma Cells.

Juraj Bodo, PhD, Jan Sedlak, DSc, Jaroslaw P. Maciejewski, MD, PhD, Eric D. Hsi, MD

Blood (2009) 114 (22): 4783.

https://doi.org/10.1182/blood.V114.22.4783.4783

Published: 2009

NARROW

Distinct Phenotypes of Myeloid Neoplasia Associated with Truncating C-CBL Mutations

Molecular and Clinical PHF6 Mutant Myeloid Neoplasia Provides Clues As to Their Pathogenesis and Therapeutic Targeting

Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell Proliferations

Hypomethylating Agent 5-Azacytidine Sensitizes Peripheral T-Cell Lymphoma to SLAMF7-Targeting Therapeutic Antibody, Elotuzumab

Inhibition of Cyclin Dependent Kinase 9 Synergistically Enhanced Venetoclax Activity in Mantle Cell Lymphoma Cells

The Synergistic Effect of Venetoclax Combined with a CDK9 Inhibitor in Primary Diffuse Large B Cell Lymphoma and Follicular Lymphoma Cells

CCMCL1: a new model of aggressive mantle cell lymphoma

Activity of ABT-199 and Acquired Resistance in Follicular Lymphoma Cells

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Triple Negative (J AK2 exon 12 /14 and MPL wild type) Myelofibrosis Have Higher Expression Of CDC25A and Greater Sensitivity To CDC25A Inhibition Compared To JAK2 Mutant Cases

Spliceosome Gene Mutations Are Frequently Found In JAK2 Negative Myelofibrosis and Associated With Worse Clinical Outcomes

Combination Of Ibrutinib With ABT-199, a BCL-2 Pathway Inhibitor: Effective Therapeutic Strategy In a Novel Mantle Cell Lymphoma Cell Line Model

The PI3K Inhibitor GS-1101 (CAL-101) Synergistically Potentiates HDAC-Induced Proliferation Inhibition and Apoptosis Through the Activation of JNK in Lymphoma Cells

Single Nucleotide Polymorphism Array (SNP-A) Genomic Profiling of Mantle Cell Lymphoma (MCL) Against a Large Control Database Reveals Recurring Copy Number Alterations (CNAs) and Copy Neutral Loss of Heterozygosity (CN-LOH)

Combination of Enzastaurin and HDAC Inhibitors Synergically Induce Apoptosis in Lymphoma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only